ARDT Valuation

Ardent Health Partners Inc

Add to Watchlist

Advanced Chart

12.200

-0.590(-4.610%)

Overview
Forecast
Valuation

ARDT Relative Valuation

ARDT's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, ARDT is overvalued; if below, it's undervalued.

Historical Valuation

Ardent Health Partners Inc(ARDT) is now in theUndervaluedzone, suggesting that its currentforward PEratio of6.46is consideredUndervaluedcompared with the five-year average of9.28.The fair price of Ardent Health Partners Inc(ARDT)is between15.38to19.85according to relative valuation methord.Compared to the current price of12.20USD, Ardent Health Partners Inc isUndervalued By 20.68%.

Relative Value

Fair Zone

15.38-19.85

Current Price：12.20

20.68%

Undervalued

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

1.54

P/B

Median3y

6.01

Median5y

6.01

6.98

FCF Yield

Median3y

4.83

Median5y

4.83

Competitors Valuation Multiple

The average P/S ratio for ARDT's competitors is 0.54, providing a benchmark for relative valuation. Ardent Health Partners Inc Corp (ARDT) exhibits a P/S ratio of 0.29, which is -46.31% above the industry average. Given its robust revenue growth of 19.33%, this premium appearsunsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

Revenue Growth

Market Cap

ARDT.N

Ardent Health Partners Inc